US FDA approves Sarepta’s gene therapy for rare muscular dystrophy in some kids
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
By Jonathan Stempel (Reuters) -Warren Buffett has donated another $4.64 billion of Berkshire Hathaway stock to five charities, boosting his…
By Chuck Mikolajczak NEW YORK (Reuters) -Meta Platforms will return to its former status as a full growth stock after…
By David Shepardson WASHINGTON (Reuters) -The U.S. Federal Trade Commission on Wednesday accused Amazon.com of enrolling millions of consumers into…
By Stephen Culp NEW YORK (Reuters) – U.S. stocks closed lower on Wednesday as Federal Reserve Chairman Jerome Powell’s congressional…
By Stephen Culp NEW YORK (Reuters) – U.S. stocks softened on Tuesday, closing in negative territory as investors began the…
(This June 20 story has been refiled to spell out the name of Healthcare of Ontario Pension Plan in paragraph…
(This June 20 story has been corrected to change share repurchase figure to $2 billion, from $2 million, in paragraph…
By Joseph Ax and Brendan O’Brien (Reuters) – Canadian aircraft detected underwater noises in the North Atlantic in the search…
By Trevor Hunnicutt and Kanishka Singh SAN FRANCISCO (Reuters) -The risks of artificial intelligence to national security and the economy…